Healthcare  |  Biotechnology
20.20 0.0 0.0%
Stock Price | Dec. 11, 2019, 4 p.m.
Bid: 0.0
Ask: 0.0
Prev. Close: 20.2
52 Week Low: 2.23
52 Week High: 20.45
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Arqule Inc is a biopharmaceutical company, engaged in the research and development of therapeutics to treat cancers and rare diseases. The objective of the company is to discover, develop and commercialize novel small molecule drugs in areas of high unmet need that will dramatically extend and improve the lives of the patients. These drugs focus on the biological pathways implicated in a range of cancers and certain non-oncology indications. Geographically, the firm operates through the region of United States.

Read more Read less

Recently Viewed Tickers

Free Stock Watchlist 06/23/2016

3 years ago

Premium Stock Watchlist Video 08/28/2015

4 years ago

Premium Stock Watchlist 08/28/2015

4 years ago